Table 2 Sequence alignment of two designed SNPRD1 siRNA against SNRPD1 and cell cycle related genes experimentally assessed in this study
From: SNRPD1 confers diagnostic and therapeutic values on breast cancers through cell cycle regulation
| Type | Gene | Accession | E value | Significance |
|---|---|---|---|---|
| siRNA-1 | PCNA | NM_182649.2 | 0.18 | |
| CCND1 | NM_053056.3 | 2.4 | ||
| CCNB1 | NM_031966.4 | 0.29 | ||
| CDK1 | NM_001786.5 | 0.068 | ||
| CDCA5 | NM_080668.4 | 1.4 | ||
| NDC80 | NM_006101.3 | 0.077 | ||
| CCNA2 | NM_001237.5 | 0.39 | ||
| SNRPD1 | NM_006938.4 | 0.0000002 | * | |
| SNRPD1 | NM_001291916.2 | 0.16 | ||
| siRNA-2 | PCNA | NM_182649.2 | 0.012 | |
| CCND1 | NM_053056.3 | 0.15 | ||
| CCNB1 | NM_031966.4 | 0.29 | ||
| CDK1 | NM_001786.5 | / | ||
| CDCA5 | NM_080668.4 | 1.4 | ||
| NDC80 | NM_006101.3 | 0.3 | ||
| CCNA2 | NM_001237.5 | 0.39 | ||
| SNRPD1 | NM_006938.4 | 0.0000002 | * | |
| SNRPD1 | NM_001291916.2 | 0.0000002 | * |